Investigate the Correlation of Growth Hormone with the Level of Some Reproductive Hormones and Certain Parameters in a Number of Iraqi-Aging and Younger Women During IVF/ICSI Cycles | ||
| Kirkuk Journal of Science | ||
| Volume 18, Issue 4, December 2023, Pages 65-73 PDF (232.79 K) | ||
| Document Type: Research Paper | ||
| DOI: 10.32894/kujss.2023.145164.1127 | ||
| Authors | ||
| Tiba Adnan kadhim* ; Lina A. Salih | ||
| Department of Biology, College of Science, University of Baghdad, Baghdad, Iraq | ||
| Abstract | ||
| An estimated 12–20% of couples struggle with infertility, which is described as not becoming pregnant after a year of trying. About one-third of these couples are infertile because of female factors, and another third are infertile because of male factors. A combination of the two may be experienced by couples in the remaining one-third. Its distributed into two groups: primary and secondary. There were a total of 60 participants, 30 of whom were older women (>35) and 30 of whom were younger women (<35). In this study, the results was a statistically highly significant positive correlation between GH and both serum and follicular fluid (FF), FSH (0.84, 0.81 mIU/ML), LH (0.76, 0.74 mIU/ML) and AMH (0.89, 0.86 mIU/ML), and there was highly significant positive correlation between GH and number of retrieval Oocyte (0.47, 0.46 mIU/ML), a negatively significant correlation was found between GH and the number of abortions (-0.10, -0.14 mIU/ML). Notably, the vast majority of the assessments of GH hormone levels in serum and follicular fluid revealed a statistically significant positive correlation with FSH, LH, and AMH, the frequency of miscarriages, the retrieval of oocytes, and infertility duration. These findings imply a strong positive correlation between GH and female fertility. As a result, much research is required to assess and estimate the importance of GH levels on women's fertility and to get an early hormone level assessment before beginning a GH-containing therapy program. | ||
| Keywords | ||
| Infertility; FSH; LH; AMH; Growth hormone | ||
| References | ||
|
[1] A. Jaiswal, T. Baliu-Souza, K. Turner, N. Nadiminty, A. Rambhatla, A. Agarwal, and et al. Sperm centriole assessment identifies male factor infertility in couples with unexplained infertility–a pilot study. European Journal of Cell Biology, 101(3): 151243, 2022, doi:10.1016/j.ejcb.2022.151243.
[2] PS. Deshpande and A. S. Gupta. Causes and prevalence of factors causing infertility in a public health facility. Journal of Human Reproductive Sciences, 12(4): 287, 2019.
[3] SK. Sunkara, B. Antonisamy, AC. Redla, and MS. Kamath. Female causes of infertility are associated with higher risk of preterm birth and low birth weight: analysis of 117 401 singleton live births following IVF. Human Reproduction, 36(3): 676–682, 2021, doi:10.1093/humrep/deaa283.
[4] J. Feng, J. Wang, Y. Zhang, Y. Zhang, L. Jia, D. Zhang, and S. Luo. The efficacy of complementary and alternative medicine in the treatment of female infertility. Evidence-Based Complementary and Alternative Medicine, 112(1), 2021, doi:10.1155/2021/6634309.
[5] MS. Abebe, M. Afework, and Y. Abaynew. Primary and secondary infertility in africa: systematic review with meta-analysis. Fertility Research and Practice, 6: 1–11, 2022, doi:10.1186/s40738-020-00090-3.
[6] AF. Hameed, IS. Ajeel, KI. Noel, and KM. Hassan. Multifactorial etiology of male and female infertility/assisted reproductive technique. Magna Scientia Advanced Biology and Pharmacy, 7(01): 001–008, 2022, doi:10.30574/msabp.2022.7.1.0083.
[7] VN. Varlas, RG. Bors, D. Albu, ON. Penes, BA. Nasui, C. Mehedintu, and AL. Pop. Social freezing: Pressing pause on fertility. International Journal of Environmental Research and Public Health, 18(15): 8088, 2021, doi:10.3390/ijerph18158088.
[8] Z. Zhang, C. He, Y. Gao, L. Zhang, Y. Song, T. Zhu, and ... G. Liu. α-ketoglutarate delays age-related fertility decline in mammals. Aging Cell, 20(2): e13291, 2021, doi:10.1111/acel.13291.
[9] V. Padmanabhan and RC. Cardoso. Neuroendocrine, autocrine, and paracrine control of follicle-stimulating hormone secretion. Molecular and cellular endocrinology, 500: 110632, 2020, doi:10.1016/j.mce.2019.110632.
[10] D. Unuane, H. Tournaye, B. Velkeniers, and K. Poppe. Endocrine disorders and female infertility. Best Practice and Research Clinical Endocrinology and Metabolism, 25(6): 861–873, 2011, doi:10.1016/j.beem.2011.08.001.
[11] HQ. Wang, WD. Zhang, B. Yuan, and JB. Zhang. Advances in the regulation of mammalian folliclestimulating hormone secretion. Animals, 11(4): 1134, 2021, doi:10.3390/ani11041134.
[12] M. Victoria, J. Labrosse, F. Krief, I. Cedrin-Durnerin, M. Comtet, and M. Grynberg. Anti mullerian hor- ¨ mone: more than a biomarker of female reproductive function. Journal of Gynecology Obstetrics and Human Reproduction, 48(1): 19–24, 2019, doi:10.1016/j.jogoh.2018.10.015.
[13] J. Bedenk, E. Vrtacnik-Bokal, and I. Virant-Klun. The role of anti-mullerian hormone (amh) in ovarian disease and infertility. Journal of Assisted Reproduction and Genetics, 37: 89–100, 2020.
[14] VS. Bonert and S. Melmed. Growth hormone. Academic Press, UK, 4th edition, 2017, doi:10.1016/B978-0-12-804169-7.00004-0.
[15] S. Duran-Ortiz, EO. List, Y. Ikeno, J. Young, R. Basu, S. Bell, and JJ. Kopchick. Growth hormone receptor gene disruption in mature-adult mice improves male insulin sensitivity and extends female lifespan. Aging Cell, 20(12): e13506, 2021, doi:10.1111/acel.13506.
[16] S. Melmed. Pathogenesis and diagnosis of growth hormone deficiency in adults. New England Journal of Medicine, 380(26): 2551–2562, 2019, doi:10.1056/NEJMra1817346.
[17] Y. O’Brien, M. Wingfield, and LC. O’Shea. Bioavailability and mobility of arsenic, cadmium, and manganese in golanti-mullerian hormone and progesterone levels in human follicular fluid are predictors of embryonic development. Reproductive Biology and Endocrinology, 17(1): 1–8, 2019, doi:10.1186/s12958-019-0492-9.
[18] SAS. Statistical Analysis System, User’s Guide. Statistical Version 9. SAS. Institute. Inc. Cary. N.C. USA, 6th edition, 2018.
[19] X. Wu, L. Zhou, J. Shi, CY. Cheng, and F. Sun. Multiomics analysis of male infertility. Biology of Reproduction, 107(1): 118–134, 2022, doi:10.1093/biolre/ioac109.
[20] S. Pajai, J. Potdar, U. Gopal, T. Banait, and KU. Gopal. A Review on the use of letrozole in female and male infertility. Cureus, 14(11): e31291, 2022, doi:10.7759/cureus.31291.
[21] S. Samal, K. Dhadwe, U. Gupta, and NK. Gupta. Epidemiological study of male infertility. Indian Medical Gazette, 5: 174–80, 2012.
[22] TA. Ahmed, SM. Ahmed, Z. El-Gammal, S. Shouman, A. Ahmed, R. Mansour, and et al. Oocyte aging: the role of cellular and environmental factors and impact on female fertility. Cell Biology and Translational Medicine, 8: 109–123, 2020, doi:10.1007/55842019456.
[23] AE. Peters, BP. Mihalas, EG. Bromfield, SD. Roman, B. Nixon, and JM. Sutherland. Autophagy in female fertility: a role in oxidative stress and aging. Antioxidants and Redox Signaling, 32(8): 550–568, 2020, doi:10.1089/ars.2019.7986.
[24] SS. Mohammed Amin and KA. Faraj. Influence of radiation on female fertility and pregnancy. Kirkuk University Journal-Scientific Studies, 16(2): 1–23, 2020, doi:10.32894/kujss.2021.168660.
[25] Prevalence of primary and secondary infertility. F. jabeen and s. khadija and s. daud. Saudi Journal of Medicine Medical Sciences, 7(1):22–28, 2023, doi:10.36348/sjm.2022.v07i01.004.
[26] R. Mazzilli, S. Medenica, AM. Di Tommaso, G. Fabozzi, V. Zamponi, D. Cimadomo, and et al. The role of thyroid function in female and male infertility: A narrative review. Journal of Endocrinological Investigation, 46(1): 15–26, 2023, doi:10.1007/s40618-022-01883-7.
[27] L. Zhang, H. Cai, W. Li, L. Tian, and J. Shi. Duration of infertility and assisted reproductive outcomes in nonmale factor infertility: can use of icsi turn the tide?. BMC Women’s Health, 22(1): 1–9, 2010, doi:10.1186/s12905-022-02062-9.
[28] A. Sharma, C. Mahajan, KN. Saraswathy, M. Puri, and N. Babu. Struggling with primary infertility: Psychological well-being and associated factors in north indian women. Journal of the Anthropological Survey of India, 71(1): 68–83, 2022, doi:10.1177/2277436X211073849.
[29] J. Khan, MS. Iftikhar, MS. Noor, R. Sulaiman, T. Qadeer, and MA. Iftikhar. Comparison of depression in women with primary and secondary infertility in patients at OB/GYN OPD at sharif medical city, lahore, pakistan. Journal of Medical and Health Sciences, 16(05): 454–454, 2022, doi:10.53350/pjmhs22165454.
[30] D. Jiesisibieke, T. Tian, X. Zhu, S. Fang, N. Zhang, J. Ma, and et al. Reproductive outcomes of conventional in vitro fertilization and intracytoplasmic sperm injection in patients with non-severe male infertility across poor and different sub-optimal ovarian response categories: a cohort study based on 30352 fresh cycles from (2009- 2019). Springer, 2023, doi:10.21203/rs.3.rs-2710388/v1.
[31] L. Chen, H. Zhou, X. Liu, J. Zhao, Q. Qi, and Q. Xie. Cycle characteristics and pregnancy outcomes of early rescue intracytoplasmic sperm injection cycles in normal and hyper-ovarian response women: A six-year retrospective study. Journal of Clinical Medicine, 12(5), 1993, doi:10.3390/jcm12051993.
[32] F. He, F. Wang, YY. ang, Z. Yuan, C. Sun, H. Zou, and L. Han. The effect of growth hormone on the metabolome of follicular fluid in patients with diminished ovarian reserve. Reproductive Biology and Endocrinology, 21(1): 1–11, 2023, doi:10.1186/s12958-023-01073-x.
[33] EJ. Owen, C. West, BA. Mason, and HS. Jacobs. Cotreatment with growth hormone of sub-optimal responders in IVF-ET. Human Reproduction, 6(4): 524–528, 1991, doi:10.1093/oxfordjournals.humrep.a137372.
[34] F. Scheffler, R. Cabry, M. Soyez, H. Copin, MB. Khalifa, A. Devaux, and R. Desailloud. Growth hormone replacement improved oocyte quality in a patient with hypopituitarism: A study of follicular fluid. in annales d’endocrinologie. Elsevier Masson, 82(6): 590–596, 2021, doi:10.1016/j.ando.2021.05.003.
[35] JL. Yovich, SL. Regan, S. Zaidi, and KN. Keane. The concept of growth hormone deficiency affecting clinical prognosis in IVF. Frontiers in Endocrinology, 10: 650, 2023, doi:10.3389/fendo.2019.00650.
[36] L. Man, Y. Chen, N. Li, Y. Luo, X. Pan, and S. Zhou. Level of IGF1 in follicular fluid associated with IVF pregnancy outcome in the application of growth hormone. Ginekologia Polska, 711, 2022, doi:10.1007/s11270-019-4221-y.
[37] J. Tapanainen, H. Martikainen, R. Voutilainen, M. Orava, A. Ruokonen, and L. Ronnberg. Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility, 58(4): 726–732, 1992, doi:10.1016/S0015-0282(16)55319-9.
[38] DM. Magalhaes, ABG. Duarte, VR. Ara ˜ ujo, IR. Brito, TG. Soares, IMT. Lima, and JR. Figueiredo. In vitro production of a caprine embryo from a preantral follicle cultured in media supplemented with growth hormone. Theriogenology, 75(1): 182–188, 2011, doi:10.1016/j.theriogenology.2010.08.004.
[39] P. Yang, R. Wu, and H. Zhang. The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI: a meta-analysis of randomized controlled trials. Reproductive Biology and Endocrinology, 18(1): 1–10, 2020, doi:10.1186/s12958-020-00632-w.
[40] W. Xue-Mei, J. Hong, Z. Wen-Xiang, and L. Yang. The effects of growth hormone on clinical outcomes after frozen–thawed embryo transfer. International Journal of Gynecology and Obstetrics, 133(3): 347–350, 2016, doi:10.1016/j.ijgo.2015.10.020.
[41] K. Liu, L. Zhang, Q. Qi, J. Li, F. Yan, and J. Hou. Growth hormone treatment improves the development of follicles and oocytes in prepubertal lambs. Journal of Ovarian Research, 16(1): 132, 2023, doi:10.1186/s13048-023- 01209-y.
[42] KL. Hull and S. Harvey. Growth hormone and reproduction: a review of endocrine and autocrine/paracrine interactions. International journal of endocrinology, 2014, 2014, doi:10.1155/2014/234014.
[43] NR. Adams and JR. Briegel. Multiple effects of an additional growth hormone gene in adult sheep. Journal of Animal Science, 83(8): 1868–1874, 2005, doi:10.2527/2005.8381868x.
[44] KN. Keane, JL. Yovich, A. Hamidi, PM. Hinchliffe, and SS. Dhaliwal. Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis. The BMJ, 7(10): e018107, 2017, doi:10.1136/bmjopen-2017-018107.
[45] J. Tesarik, M. Galan-L azaro, C. Conde-L opez, AM. Chiara-Rapisarda, and R. Mendoza-Tesarik. The effect of GH administration on oocyte and zygote quality in young women with repeated implantation failure after IVF. Frontiers in endocrinology, 11: 519572, 2020, doi:10.3389/fendo.2020.519572.
[46] J. Zhu, Y. Wang, L. Chen, P. Liu, R. Li, and J. Qiao. Growth hormone supplementation may not improve live birth rate in poor responders. Frontiers in Endocrinology, 11: 1, 2020, doi:10.3389/fendo.2020.00001. | ||
|
Statistics Article View: 99 PDF Download: 93 |
||